Chinese Journal of Chromatography ›› 2020, Vol. 38 ›› Issue (11): 1294-1301.DOI: 10.3724/SP.J.1123.2020.02008
Previous Articles Next Articles
Xiuyao ZHANG(), Xinxin CAI, Xiaoyi ZHANG, Ruifen LI
Received:
2020-02-19
Online:
2020-11-08
Published:
2020-12-11
Contact:
Xiuyao ZHANG
Xiuyao ZHANG, Xinxin CAI, Xiaoyi ZHANG, Ruifen LI. Simultaneous determination of paraquat and diquat in plasma and urine by ion chromatography-triple quadrupole mass spectrometry[J]. Chinese Journal of Chromatography, 2020, 38(11): 1294-1301.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chrom-china.com/EN/10.3724/SP.J.1123.2020.02008
Compound | Precursor ion (m /z ) | Product ion (m /z ) | Declustering potential/V | Collision energy/eV |
* Quantitative ion. | ||||
Paraquat | 171.1 | 155.1* | 130 | 39 |
77.0 | 45 | |||
Paraquat-d8 | 179.1 | 162.1* | 150 | 39 |
Diquat | 157.0 | 130.1* | 185 | 33 |
78.0 | 36 | |||
Diquat-d4 | 186.1 | 158.1* | 150 | 30 |
Table 1 MS parameters for paraquat and diquat and their isotope internal standards
Compound | Precursor ion (m /z ) | Product ion (m /z ) | Declustering potential/V | Collision energy/eV |
* Quantitative ion. | ||||
Paraquat | 171.1 | 155.1* | 130 | 39 |
77.0 | 45 | |||
Paraquat-d8 | 179.1 | 162.1* | 150 | 39 |
Diquat | 157.0 | 130.1* | 185 | 33 |
78.0 | 36 | |||
Diquat-d4 | 186.1 | 158.1* | 150 | 30 |
Compound | Matrix | Added/(μg/L) | Found/(μg/L) | Recovery/% | RSD/% |
PQ | plasma | 1.0 | 1.17 | 117 | 16.7 |
3.0 | 3.12 | 104 | 8.9 | ||
20 | 18.7 | 93.5 | 9.0 | ||
120 | 113 | 94.2 | 3.4 | ||
urine | 1.0 | 1.18 | 118 | 14.9 | |
3.0 | 3.15 | 105 | 5.6 | ||
20 | 18.9 | 94.5 | 7.2 | ||
120 | 108 | 90.0 | 6.8 | ||
DQ | plasma | 0.5 | 0.47 | 94.0 | 13.2 |
1.5 | 1.68 | 112 | 5.5 | ||
10 | 9.17 | 91.7 | 6.2 | ||
60 | 58.1 | 96.8 | 2.8 | ||
urine | 0.5 | 0.58 | 116 | 17.3 | |
1.5 | 1.66 | 111 | 6.4 | ||
10 | 10.5 | 105 | 6.3 | ||
60 | 59.5 | 99.2 | 2.4 |
Table 2 Spiked recoveries and RSDs of paraquat and diquat in blank plasma and urine samples (n =6)
Compound | Matrix | Added/(μg/L) | Found/(μg/L) | Recovery/% | RSD/% |
PQ | plasma | 1.0 | 1.17 | 117 | 16.7 |
3.0 | 3.12 | 104 | 8.9 | ||
20 | 18.7 | 93.5 | 9.0 | ||
120 | 113 | 94.2 | 3.4 | ||
urine | 1.0 | 1.18 | 118 | 14.9 | |
3.0 | 3.15 | 105 | 5.6 | ||
20 | 18.9 | 94.5 | 7.2 | ||
120 | 108 | 90.0 | 6.8 | ||
DQ | plasma | 0.5 | 0.47 | 94.0 | 13.2 |
1.5 | 1.68 | 112 | 5.5 | ||
10 | 9.17 | 91.7 | 6.2 | ||
60 | 58.1 | 96.8 | 2.8 | ||
urine | 0.5 | 0.58 | 116 | 17.3 | |
1.5 | 1.66 | 111 | 6.4 | ||
10 | 10.5 | 105 | 6.3 | ||
60 | 59.5 | 99.2 | 2.4 |
Matrix | PQ | DQ | |||
ME/% (RSD/%) | RE/% (RSD/%) | ME/% (RSD/%) | RE/% (RSD/%) | ||
Plasma | 84.2-89.3 (5.4-6.2) | 92.1-96.9 (7.4-8.2) | 84.7-91.1 (5.7-6.5) | 90.4-95.3 (6.3-7.2) | |
Urine | 50.3-58.4 (5.9-7.8) | 93.2-98.4 (6.9-8.0) | 51.9-59.4 (6.4-7.4) | 94.2-98.7 (6.7-8.7) |
Table 3 Matrix effects (MEs) and recoveries of the extraction procedure (REs) of the paraquat and diquat in plasma and urine samples (n =5)
Matrix | PQ | DQ | |||
ME/% (RSD/%) | RE/% (RSD/%) | ME/% (RSD/%) | RE/% (RSD/%) | ||
Plasma | 84.2-89.3 (5.4-6.2) | 92.1-96.9 (7.4-8.2) | 84.7-91.1 (5.7-6.5) | 90.4-95.3 (6.3-7.2) | |
Urine | 50.3-58.4 (5.9-7.8) | 93.2-98.4 (6.9-8.0) | 51.9-59.4 (6.4-7.4) | 94.2-98.7 (6.7-8.7) |
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||